32nd Annual San Antonio Breast Cancer Symposium
December 9-13, 2009
San Antonio, TX
AACR Outstanding Investigator Award for Breast Cancer Research, supported by an educational grant from Susan G. Komen for the Cure®
Charles M. Perou, Ph.D. gave an award lecture titled, "Therapeutic Implications of the Molecular Portraits of Breast Cancer" on Thursday, December 10, 2009.
AACR Distinguished Lectureship in Breast Cancer Research
Robert A. Weinberg, Ph.D. gave an award lecture titled, "Breast Cancer Stem Cells and the Epithelial-Mesenchymal Transition" on Friday, December 11, 2009.
The 2009 San Antonio Breast Cancer Symposium (SABCS) was the second Symposium presented by the CTRC, AACR, and the Baylor College of Medicine. The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer. By combining their respective strengths, the 2009 San Antonio Breast Cancer Symposium encompassed the full spectrum of breast cancer research and facilitated the rapid transition of new knowledge into improved care for breast cancer patients. Over 8,400 attendees from nearly 100 countries participated in the 2009 Symposium.
Each year, SABCS attracts academic and private physicians and researchers, as well as other health care professionals focused on curing breast cancer, to discuss and learn about new and late-breaking research including experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new findings from clinical trials. With the addition of the AACR as a symposium collaborator, the program attracts more thought-leaders and high-quality proffered papers in basic and translational breast cancer research as well as increases the participation of young investigators by providing superior education and training opportunities for the next generation of breast cancer researchers. AACR's scientific prestige in basic, translational, and clinical cancer research helps to create a unique and comprehensive scientific meeting that advances breast cancer research for the benefit of patients.